This report focuses on the predictive breast cancer gene testing markets in Europe (France, Germany, Italy, Spain, and the UK), and identifies unmet needs in the market, physician attitudes towards current gene testing, and the future of gene testing in the face of rapid technological advancement.
NYSE: MHS) gene testing analysis found that 38 percent of patients prescribed Plavix (clopidogrel)-an anti-platelet drug used to prevent blood clots, heart attack and stroke-were also using another drug that would impede its effectiveness.
The AKROBATS (Additional KIF6 Risk Offers Better Adherence to Statins) trial is the first "real-world" study designed to prospectively evaluate the impact of the KIF6 gene testing on patient adherence to cholesterol-lowering drugs.
This comprehensive resource is designed to equip physicians and other healthcare professionals who are not trained in genetics with independent, evidence-based information to help them understand the complexities of BRCA1/2 gene testing.
In its 1999 ACMG Position Statement on Gene Patents and Accessibility of Gene Testing, which was reaffirmed in 2005, ACMG stated that: "It is the American College of Medical Genetics' position that genes and their mutations are naturally occurring substances that should not be patented.